AI-generated summary
The authors report a randomized clinical trial of 30 intrabony periodontal defects treated with bone matrix plus either a single 810 nm or dual 810 and 650 nm photobiomodulation, or a control. Dual-wavelength treatment was associated with greater pocket depth reduction, defect depth reduction, linear bone fill and lower periodontal pathogen levels at the reported time points.
- Participants
- 30
- Who or what was studied
- Patients with intrabony periodontal defects
- Wavelengths
- 810, 650 nm
- Limits stated in the abstract
- The abstract does not describe the sample size per group or the certainty of the findings, and results are reported only for selected outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm, 650 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Trial registration, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.